Journal DOI 10.68956/dyh5-kwte

Creative Commons source reading · Headache and migraine

Validation of the Headache Impact Test (HIT-6) in patients with chronic migraine.

Regina Rendas-Baum; Min Yang; Sepideh F Varon; Lisa M Bloudek; Ronald E DeGryse; Mark Kosinski

Originally published in Health and quality of life outcomes · 2014-08-01

From the article

Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.

Abstract

Background The Headache Impact Test (HIT)-6 was developed and has been validated in patients with various types of headache. The objective of this study was to report the psychometric properties of the HIT-6 among patients with chronic migraine. Methods Data came from two international, multicenter, randomized, double-blind, placebo-controlled clinical trials of chronic migraine patients (N = 1,384) undergoing prophylaxis therapy. Confirmatory factor analysis and differential item functioning (DIF) analysis were used to test the latent structure and cross-cultural comparability of the HIT-6. Reliability, construct validity, and responsiveness were assessed. Two sets of criterion groups were used: (1) 28-day headache frequency: Results Measurement invariance tests supported the stability of the HIT-6 latent structure across studies. DIF analysis supported cross-cultural comparability. Good reliability was observed across studies (Cronbach's α: 0.75-0.92; intraclass correlation coefficient: 0.76-0.80). HIT-6 scores correlated strongly (-0.86 to -0.59) with scores of the Migraine-Specific Quality-of-Life Questionnaire.

Discussion

The findings of the current study support the stability of the HIT-6 measurement model, the tool’s construct validity, and its ability to detect change in clinical indicators of headache in two independent samples of chronic migraine patients undergoing treatment. Using recommended guidelines for interpretation of change in clinical indicators of headache [8], we found that the HIT-6 captured different levels of change exceptionally well, as indicated by measures of effect size.

Conclusions

The evidence presented in the current study and its consistency with results from prior studies suggest that the HIT-6 has excellent properties to measure the impact of headache across a wide spectrum of headache frequency, including chronic migraine, and in different clinical and research settings.

Editorial reading guide

  • Which patient population and reference standard did the authors use?
  • Was the finding validated in a separate cohort, and how might patient selection affect it?